|
Volumn 7, Issue 11 SUPPL., 2001, Pages
|
Recent perspectives on the diagnosis and treatment of generalized anxiety disorder
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPRAZOLAM;
ANTIDEPRESSANT AGENT;
ANTIHISTAMINIC AGENT;
ANXIOLYTIC AGENT;
BENZODIAZEPINE DERIVATIVE;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
BUSPIRONE;
CHLORAL HYDRATE;
CLONAZEPAM;
DIAZEPAM;
DIPHENHYDRAMINE;
FLUOXETINE;
HYDROXYZINE;
HYPNOTIC SEDATIVE AGENT;
LORAZEPAM;
NEUROTRANSMITTER;
NORADRENALIN UPTAKE INHIBITOR;
PAROXETINE;
PLACEBO;
PROPANOL;
SEROTONIN UPTAKE INHIBITOR;
SERTRALINE;
TRICYCLIC ANTIDEPRESSANT AGENT;
VENLAFAXINE;
ANXIETY;
ANXIETY NEUROSIS;
BEHAVIOR THERAPY;
BIOCHEMISTRY;
CHRONIC DISEASE;
CLINICAL FEATURE;
CLINICAL TRIAL;
COGNITIVE THERAPY;
COMORBIDITY;
DEPRESSION;
DISEASE CLASSIFICATION;
DISEASE COURSE;
DOSE RESPONSE;
DRUG ACTIVITY;
DRUG CLASSIFICATION;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG HALF LIFE;
DRUG MECHANISM;
DRUG RESPONSE;
DRUG SAFETY;
EXPERIENCE;
FAMILIAL INCIDENCE;
HEREDITY;
HUMAN;
MANAGED CARE;
NEUROBIOLOGY;
NEUROLOGIC DISEASE;
NEUROTRANSMITTER RELEASE;
PATHOLOGICAL ANATOMY;
PATIENT COUNSELING;
PREVALENCE;
PRIORITY JOURNAL;
PSYCHOANALYSIS;
PSYCHOTHERAPY;
QUALITY OF LIFE;
REVIEW;
SCREENING;
SUPPORT GROUP;
SUSTAINED DRUG RELEASE;
SYMPTOMATOLOGY;
ANTI-ANXIETY AGENTS;
ANTIDEPRESSIVE AGENTS;
ANXIETY DISORDERS;
COMBINED MODALITY THERAPY;
COMORBIDITY;
HUMANS;
MANAGED CARE PROGRAMS;
PSYCHOTHERAPY;
UNITED STATES;
|
EID: 0034789255
PISSN: 10880224
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (15)
|
References (35)
|